Medzown
Medzown is a Boston-based precision medicine company whose AI-powered analytics platform matches patients with cancer, rare, and complex diseases to clinical trials and advanced treatments, serving health plans, self-insured employers, pharmaceutical sponsors, providers, and patients through value-based enterprise contracts and pharma recruitment services.
- Company typePrivate
- Founded2022
- HeadquartersJupiter, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Medzown does
Medzown, Inc. is a Boston-based precision medicine management company that uses an AI-powered predictive analytics platform to identify patients with cancer, rare diseases, and complex conditions and match them to clinical trials and advanced treatments. The platform processes millions of data points from medical and pharmacy claims, genomic profiles, and global trial registries, analyzing 50,000+ treatment and trial options daily and 1,000+ options per case, with every recommendation vetted by Precision Medicine Scientists (15+ years average clinical research experience) and grounded in peer-reviewed clinical evidence. Dedicated Patient Navigators handle record collection, logistics, provider communication, and trial enrollment support, and the system is HIPAA-compliant.
Medzown serves four customer segments: (1) health plans and self-insured employers, for whom it identifies high-cost members (the 6-10% who generate ~50% of high-cost claims) from claims data, delivers value-based cost management with a stated 3:1 minimum ROI, and helps satisfy fiduciary obligations under the Consolidated Appropriations Act of 2021; (2) pharmaceutical companies, providing pre-screened, treatment-eligible patients to accelerate trial recruitment; (3) healthcare providers, offering curated treatment insights and clinical trial connections that save 20+ hours of research per complex case; and (4) patients with cancer, rare, or complex diagnoses, who access the service at no additional cost through participating health plans or employers.
The business model combines subscription-style, value-based enterprise contracts with health plans and self-insured employers (multi-year, with savings-shared economics) and managed-services revenue from pharma trial recruitment. Distribution is primarily direct enterprise sales to payers and self-insured employers, supplemented by channel partnerships such as the June 2026 collaboration with Sun Life U.S., which gives Medzown reach into Sun Life's stop-loss clients and self-insured employer groups. Publicly disclosed outcomes include 67% average savings on complex-member spend, 75% of patients matched to a viable trial within their first review, $78,000 average drug cost avoided per oncology trial patient, and an 85 NPS, though revenue, funding, and customer counts are not publicly disclosed.
Medzown firmographics
Firmographics- Name
- Medzown
- Legal name
- Medzown, Inc.
- Website
- https://medzown.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Medzown is a Boston-based precision medicine company whose AI-powered analytics platform matches patients with cancer, rare, and complex diseases to clinical trials and advanced treatments, serving health plans, self-insured employers, pharmaceutical sponsors, providers, and patients through value-based enterprise contracts and pharma recruitment services.
- Ownership category
- akta.pro rank
Medzown industry classification
Industry- Product category
- Precision Medicine Analytics Platform
- NAICS
- Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151)
- SIC
- Services-Health Services (8000), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)
- akta.pro secondary industry
- Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored) (HLALACAK)
Keywords
Where Medzown is headquartered
LocationHeadquarters
- HQ city
- Jupiter
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Medzown business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Revenue model
- Health Plan/Payer Services: Medzown generates revenue by providing precision medicine management services to health plans and self-insured employers. The company identifies high-cost members, matches them to clinical trials, and reduces specialty drug costs. Revenue is derived from value-based arrangements where savings on high-cost claims are shared with payers.
- Pharma Clinical Trial Recruitment: Medzown earns revenue from pharmaceutical companies by providing pre-screened, qualified patients for clinical trials. This accelerates trial enrollment timelines and reduces under-enrollment issues that cost sponsors up to $8M per day of delay.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Patient access at no additional cost |
| Subscription | Multi-year contract | Health Plan enterprise pricing |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Medzown product offering
Product offeringCore offering
Medzown operates an AI-powered precision medicine platform that analyzes medical and pharmacy claims data, genomic profiles, and global trial registries to identify patients with cancer, rare diseases, and complex conditions and match them to personalized treatment options and clinical trials. The platform is paired with human Precision Medicine Scientists (15+ years of clinical research experience) and dedicated Navigators who validate AI recommendations, curate peer-reviewed evidence, and guide patients through enrollment. It is delivered to health plans, self-insured employers, pharma sponsors, and healthcare providers as a value-based service.
Product overview
Medzown is a novel precision medicine ecosystem offering a unified platform that combines AI-powered analytics, Precision Medicine Scientists, and dedicated Navigators to connect patients with cancer, rare diseases, and complex conditions to appropriate clinical trials and advanced treatments. The core AI-Powered Precision Medicine Platform processes millions of data points daily to identify and match patients, supported by expert Scientist Services and Navigator Services. The company serves four distinct segments: Health Plans (employer-sponsored cost management), Pharma (clinical trial recruitment), Healthcare Providers (treatment insights and trial access), and Individuals/Patients (direct access to trials). All recommendations are human-validated by scientists and supported by peer-reviewed clinical evidence.
Differentiator
Problem solved
Functional benefit
Products and services
- AI-Powered Precision Medicine Platform Scalable AI platform that processes millions of data points from genomic profiles, medical and pharmacy claims, and global trial registries to identify eligible patients and match them to the most promising treatment options and clinical trials. Foundation of all Medzown offerings.
- Precision Medicine Scientist Services Expert scientists with an average of 15+ years of clinical research experience who curate, validate, and match each patient to the most promising treatment options and clinical trials, with all insights supported by peer-reviewed clinical evidence.
- Patient Navigator Services Dedicated Navigators who guide patients and their families through every step of the healthcare journey, handling record collection, logistics coordination, provider communication, and trial enrollment support.
- Health Plan Solutions Comprehensive solution for health plans that identifies eligible members from claims data, engages members directly to secure consent, develops individualized treatment strategies through AI and Precision Medicine Scientists, and provides ongoing navigation with cost savings tracking. Delivers minimum 3:1 ROI.
- Pharma Solutions Clinical trial recruitment solution for pharmaceutical companies that identifies and pre-screens eligible patients from payer medical/Rx claims, matches them to protocols through Precision Medicine Scientist review, and coordinates enrollment with trial sites to accelerate recruitment timelines.
- Healthcare Provider Support Provider-facing tools including curated, patient-specific treatment insights, streamlined prior authorizations, clinical trial connections beyond institutional walls, and reduced administrative burden, saving 20+ hours of research time per complex case.
Quantifiable outcome
- 67% average savings on complex-member spend
- +6 more outcomes
Companies that use Medzown
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Medzown technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature4 records
Medzown partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Sun Life U.S.coreSun Life U.S. and Medzown announced a collaboration to expand access to clinical trials for employees at self-insured employers across the United States. Medzown's AI-powered predictive analytics platform will identify patients with cancer or complex conditions and connect them to appropriate clinical trials before high-cost claims escalate. The partnership allows Sun Life's stop-loss clients to use Medzown's platform to address high-cost claims, with cancer costs averaging $252,000 per individual per year and ortho/MSK conditions averaging $120,000.
Scale indicators13 records
Recent moves4 records
Expansion highlights5 records
Medzown competitors and assessment
Company assessmentDirect peers
- Trial Library: Trial Library is an AI-powered clinical trial matching platform focused on community oncology, connecting patients to relevant trials through provider workflows — a focused peer competing for similar provider- and payer-driven trial enrollment opportunities.
- ConcertAI: ConcertAI is an AI-driven oncology real-world evidence and clinical trial solutions company serving biopharma and providers — overlapping with Medzown's pharma trial-recruitment and payer-facing precision medicine analytics.
- Tempus: Tempus is an AI-powered precision medicine company that combines genomic sequencing, clinical data, and analytics to support oncology treatment selection and clinical trial enrollment — directly comparable to Medzown's AI precision medicine and trial-matching platform for cancer patients.
- Deep 6 AI: Deep 6 AI uses AI and NLP to match patients to clinical trials in real time from structured and unstructured EHR data — overlapping directly with Medzown's core AI clinical trial matching value proposition for complex patients.
- Mendel Health: Mendel (now part of Whitespace) built an AI clinical trial matching and real-world evidence platform for oncology and rare disease — directly comparable to Medzown's patient-to-trial matching and precision medicine analytics.
- Massive Bio: Massive Bio is an AI-driven clinical trial matching and enrollment platform focused on oncology, serving patients, providers, and pharma — closely mirroring Medzown's multi-stakeholder precision medicine and trial recruitment model.
Broad incumbents
- Foundation Medicine: Foundation Medicine (Roche subsidiary) provides comprehensive genomic profiling that informs targeted therapy selection and clinical trial enrollment for oncology — comparable as a precision-medicine incumbent serving similar therapy and trial decisions.
- Caris Life Sciences: Caris Life Sciences offers molecular profiling, AI-driven analytics, and a clinical trial connector for oncology patients — a broader precision medicine incumbent with significant overlap in therapy matching and trial access for complex cancer patients.
- IQVIA: IQVIA is a global clinical research and commercial services giant with AI-enabled trial feasibility, patient recruitment, and real-world evidence offerings — a broad incumbent competing for pharma trial-recruitment budgets that Medzown also targets.
- Flatiron Health: Flatiron Health (Roche subsidiary) operates an oncology-specific EHR and real-world data platform used for clinical trial matching and research — a broader incumbent with overlapping precision oncology and trial-enablement capabilities.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Medzown social profiles
Digital presenceMedzown compliance and trust
Trust signalCompliance1 record
Medzown financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medzown leadership team
Management profileNumber of profiles
Profiles5 records
Medzown funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medzown M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medzown
What does Medzown do?
Medzown operates an AI-powered precision medicine platform that analyzes medical and pharmacy claims data, genomic profiles, and global trial registries to identify patients with cancer, rare diseases, and complex conditions and match them to personalized treatment options and clinical trials. The platform is paired with human Precision Medicine Scientists (15+ years of clinical research experience) and dedicated Navigators who validate AI recommendations, curate peer-reviewed evidence, and guide patients through enrollment. It is delivered to health plans, self-insured employers, pharma sponsors, and healthcare providers as a value-based service.
Is Medzown a public or private company?
Medzown is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Medzown founded?
Medzown was founded in 2022. It employs 11 to 50 people.
Where is Medzown based?
Medzown is headquartered in Jupiter, United States, in the North America region.
How does Medzown make money?
Two revenue lines are on record. Health Plan/Payer Services are the primary driver. The others are pharma Clinical Trial Recruitment.
Who are Medzown's main competitors?
Direct peers on record are Trial Library, ConcertAI, Tempus, Deep 6 AI, Mendel Health and Massive Bio. Broad incumbents are Foundation Medicine, Caris Life Sciences, IQVIA and Flatiron Health.
Does Medzown have an API?
No public API is recorded for Medzown.
What industry is Medzown in?
Medzown's product category is Precision Medicine Analytics Platform. Its primary akta.pro industry code is HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms, with a secondary code of HLALACAK, Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored). Its NAICS code is 541511 and its SIC code is 8000.